我们能用脉络膜上腔植入物取得成功吗？
Can We Ever Win with a Suprachoroidal Implant?
作者信息
Au Leon, Bhartiya Shibal
机构信息
Department of Ophthalmology, Manchester Royal Eye Hospital, Manchester, United Kingdom.
Department of Ophthalmology, Fortis Memorial Research Institute, Gurugram, Haryana, India.
出版信息
J Curr Glaucoma Pract. 2023 Apr-Jun;17(2):55-57. doi: 10.5005/jp-journals-10078-1410.
Abstract
Au L, Bhartiya S. Can We Ever Win with a Suprachoroidal Implant? J Curr Glaucoma Pract 2023;17(2):55-57.
摘要
欧 L，巴蒂亚 S。我们能通过脉络膜上腔植入物取得成功吗？《当代青光眼实践杂志》2023 年；17(2):55 - 57。
相似文献
1
Can We Ever Win with a Suprachoroidal Implant?我们能用脉络膜上腔植入物取得成功吗？
J Curr Glaucoma Pract. 2023 Apr-Jun;17(2):55-57. doi: 10.5005/jp-journals-10078-1410.
2
The Suprachoroidal Route in Glaucoma Surgery.青光眼手术中的脉络膜上腔途径
J Curr Glaucoma Pract. 2016 Jan-Apr;10(1):13-20. doi: 10.5005/jp-journals-10008-1197. Epub 2016 May 12.
3
Glaucoma Screening: Is AI the Answer?青光眼筛查：人工智能是答案吗？
J Curr Glaucoma Pract. 2022 May-Aug;16(2):71-73. doi: 10.5005/jp-journals-10078-1380.
4
Current Glaucoma Practice: The Covid-19 Impact.当前青光眼诊疗实践：新冠疫情的影响
J Curr Glaucoma Pract. 2020 Jan-Apr;14(1):1-2. doi: 10.5005/jp-journals-10078-1275.
5
Niacinamide and Neuroprotection: The Glaucoma Holy Grail.烟酰胺与神经保护：青光眼的圣杯
J Curr Glaucoma Pract. 2022 Sep-Dec;16(3):141-143. doi: 10.5005/jp-journals-10078-1390.
6
The Metabolic Shift: Unraveling the Potential of the Ketogenic Diet in Glaucoma Management.代谢转变：揭示生酮饮食在青光眼治疗中的潜力
J Curr Glaucoma Pract. 2024 Apr-Jun;18(2):43-44. doi: 10.5005/jp-journals-10078-1435.
7
Suprachoroidal Hemorrhage after XEN Gel Implant Requiring Surgical Drainage.XEN凝胶植入术后需手术引流的脉络膜上腔出血
J Curr Glaucoma Pract. 2022 May-Aug;16(2):132-135. doi: 10.5005/jp-journals-10078-1378.
8
The Quest for the Holy Grail of Glaucoma Surgery: Does Cypass Herald the End?青光眼手术圣杯的探寻：Cypass术是否宣告终结？
J Curr Glaucoma Pract. 2018 Sep-Dec;12(3):99-101. doi: 10.5005/jp-journals-10028-1252.
9
Is GATT the Answer?关贸总协定是答案吗？
J Curr Glaucoma Pract. 2023 Oct-Dec;17(4):167-168. doi: 10.5005/jp-journals-10078-1425.
10
Minimally Invasive Glaucoma Surgery-to Remove or Preserve the Trabecular Meshwork: That is the Question?微创青光眼手术——切除还是保留小梁网：这是个问题？
J Curr Glaucoma Pract. 2021 May-Aug;15(2):47-51. doi: 10.5005/jp-journals-10078-1299.
引用本文的文献
1
Meta-Analysis of MINIject vs. Two iStents as Standalone Treatment for Glaucoma with 24 Months of Follow-Up.MINIject与两种iStent作为青光眼独立治疗方法的24个月随访的荟萃分析。
J Clin Med. 2024 Dec 17;13(24):7703. doi: 10.3390/jcm13247703.
本文引用的文献
1
Trabeculectomy Augmented with Limited Deep Sclerectomy and Cyclodialysis with Use of Scleral Tissue as a Spacer.采用巩膜组织作为间隔物的有限深层巩膜切除术联合睫状体分离术强化小梁切除术
J Ophthalmic Vis Res. 2022 Nov 29;17(4):596-600. doi: 10.18502/jovr.v17i4.12342. eCollection 2022 Oct-Dec.
2
Microinvasive glaucoma surgery: a review and classification of implant-dependent procedures and techniques.微创青光眼手术：一种依赖植入物的手术和技术的综述和分类。
Acta Ophthalmol. 2022 Mar;100(2):e327-e338. doi: 10.1111/aos.14906. Epub 2021 May 14.
3
Ethics of Glaucoma Widgets.青光眼辅助设备的伦理学
J Curr Glaucoma Pract. 2020 Sep-Dec;14(3):77-80. doi: 10.5005/jp-journals-10078-1288.
4
Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial.MINIject 引流系统治疗失控性青光眼的 STAR-I 人体首次试验 2 年结果。
Br J Ophthalmol. 2022 Jan;106(1):65-70. doi: 10.1136/bjophthalmol-2020-316888. Epub 2020 Oct 3.
5
A European Study of the Performance and Safety of MINIject in Patients With Medically Uncontrolled Open-angle Glaucoma (STAR-II).MINIject 在患有药物控制不佳的开角型青光眼患者中的性能和安全性的欧洲研究（STAR-II）。
J Glaucoma. 2020 Oct;29(10):864-871. doi: 10.1097/IJG.0000000000001632.
6
A First-in-Human Study of the Efficacy and Safety of MINIject in Patients with Medically Uncontrolled Open-Angle Glaucoma (STAR-I).MINIject 在未经药物控制的开角型青光眼患者中的疗效和安全性的首次人体研究（STAR-I）。
Ophthalmol Glaucoma. 2019 Sep-Oct;2(5):290-297. doi: 10.1016/j.ogla.2019.06.001. Epub 2019 Jun 21.
7
Efficacy of Combined Suprachoroidal Stent and Cataract Surgery in Patients With Glaucoma.联合巩膜支架和白内障手术治疗青光眼的疗效。
J Glaucoma. 2020 Aug;29(8):627-638. doi: 10.1097/IJG.0000000000001554.
8
The STARflo™ glaucoma implant: a single-centre experience at 24 months.STARfloTM 青光眼植入物：24 个月单中心经验。
Graefes Arch Clin Exp Ophthalmol. 2019 Dec;257(12):2699-2706. doi: 10.1007/s00417-019-04461-5. Epub 2019 Oct 12.
9
The Quest for the Holy Grail of Glaucoma Surgery: Does Cypass Herald the End?青光眼手术圣杯的探寻：Cypass术是否宣告终结？
J Curr Glaucoma Pract. 2018 Sep-Dec;12(3):99-101. doi: 10.5005/jp-journals-10028-1252.
10
The Safety and Efficacy of Supraciliary Stenting Following Failed Glaucoma Surgery.经失败的青光眼手术后行眉弓下支架植入的安全性和疗效。
Am J Ophthalmol. 2018 Jun;190:191-196. doi: 10.1016/j.ajo.2018.03.043. Epub 2018 Apr 9.
Zotero 插件